Advisory Board

Celimmune is honored to be served by a prestigious, knowledgeable, experienced advisory board, led by Markku Mäki, M.D., Ph.D., and including Anthony J. DiMarino Jr., M.D., Ciarán P. Kelly, M.D., Bana Jabri, M.D., Ph.D., and Joseph A. Murray, M.D.

Markku Mäki, M.D., Ph.D., Chairman of Celimmune Advisory Board

Markku Mäki, M.D., Ph.D., is a pediatric gastroenterologist and Professor of Pediatrics at the University of Tampere, and Chief Physician in the Department of Pediatrics at the Tampere University Hospital in Tampere, Finland. Dr. Mäki earned his medical degree from the University of Turku and his doctoral degree from the University of Tampere.
Dr. Mäki has performed academic and clinical research in celiac disease and small intestine mucosal biology for more than 35 years. He has authored and co-authored more than 300 scientific publications on celiac disease, and has been recognized for his research in 2010 with the Wm. K. Warren Jr. Prize in Celiac Disease in Clinical/Translational Research, San Diego, California.

Dr. Mäki is a permanent member of the Finnish Academy of Science and Letters and the President of Finland has granted him the honor of Knight, First Class, of the Order of the White Rose of Finland in 2006. He has also served as the President of the Finnish Celiac Society and is the chairman of its Medical Advisory Board. He works also as an Advisory Board member for several companies working within celiac disease and has organized several international scientific celiac disease symposia.

Anthony J. DiMarino Jr., M.D.

Anthony J. DiMarino, Jr., M.D., currently serves as the William Rorer Professor of Medicine, Chief of the Division of Gastroenterology and Hepatology at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. He is also the founder of the first Adult Celiac Center in Philadelphia, which is currently at Thomas Jefferson University Hospital. He received his medical degree from Hahnemann Medical College and completed his internal medicine residency and fellowship in gastroenterology and served on the full-time faculty at the Hospital of the University of Pennsylvania.

Dr. DiMarino’s research interests have primarily been in the areas of esophageal, small intestinal motility, celiac disease and the safety of gastrointestinal endoscopy. He is the author of the “White Paper,” commissioned by the Food and Drug Administration, which remains the standard for reprocessing endoscopic gastrointestinal instruments to protect patient safety between GI Endoscopic procedures. Dr. DiMarino is the author of more than 300 original papers, chapters, and abstracts including his most recent textbook, co-authored with Sidney Cohen, M.D. titled “Extraintestinal Manifestations of GERD” and, along with the Chief of Gastroenterology, Stanley Benjamin, MD, at Georgetown University, “Gastrointestinal Disease, An Endoscopic approach” which is in its second edition.

Dr. DiMarino has been honored as “Physician of the Year” by the Delaware Valley Chapter of the Crohn’s & Colitis Foundation of America and as a “Top Doc” in Philadelphia Magazine from 1991 through 2015. In 2006 through 2015 he was named by Castle Connolly Medical Ltd. as one of America’s “Top Doctors.” In 2012, he was one of six appointed to the National United Healthcare Gastrointestinal Scientific Advisory Board, as well as to the Thomas Jefferson University Hospital Board of Trustees.

Ciarán P. Kelly, M.D.

Dr. Ciarán P. Kelly, M.D. is Professor of Medicine at Harvard Medical School and Director of Gastroenterology Training at Beth Israel Deaconess Medical Center, Boston, Massachusetts USA. Dr. Kelly earned his medical degree from Trinity College in Dublin, Ireland where he was a Foundation Scholar and recipient of numerous academic awards. Dr Kelly has also received postgraduate clinical and research awards from the Crohn’s and Colitis Foundation of America, the American Gastroenterological Association and the National Institutes of Health. He is an American Gastroenterology Association Fellow and a Fellow of the American College of Gastroenterology.

Dr. Kelly has engaged in patient care and research in Celiac disease for more than 20 years. In 2004 he was a founder of the Celiac Center at BIDMC and serves as its Director. In 2013 he co-founded the Celiac Research Program at Harvard Medical School.

Dr. Kelly is an internationally recognized expert in the diagnosis and management of celiac disease and, in his clinical practice, specializes in difficult-to-treat enteropathy. He also leads research programs on the pathogenesis of celiac disease, its diagnosis and new approaches to treatment. He has served as a committee member of the NIH, Center for Scientific Review as well as FDA, CDC and NIH committees on celiac disease and C. difficile infection. Dr. Kelly is the author of more than 200 clinical and basic research book chapters, invited reviews, and original research articles appearing in medical and scientific journals including Gastroenterology, Vaccine, Infection & Immunity, The Journal of Clinical Investigation, The Lancet and The New England Journal of Medicine.

Bana Jabri, M.D., Ph.D.

Bana Jabri, M.D. Ph.D. is one of the leading researchers of celiac disease in the world and has directed the research team at The University of Chicago Celiac Disease Center since 1999. With her leadership, the University of Chicago Celiac Disease Center research team continues to make great strides in determining what triggers the abnormal reaction to gluten in celiac disease.

Dr. Jabri is a professor in the Departments of Medicine, Pathology and Pediatrics at the University of Chicago Medical Center, and is a member of the Committee on Immunology. She is Director of Research of the University of Chicago Celiac Disease Center, the Co-director of the University of Chicago Digestive Disease Research Core Center (one of the 17 NIH sponsored Centers of Excellence for Digestive Disease Research in the United States) and the Vice Chair for Research in the Department of Medicine.

Dr. Jabri completed her residency in pediatric gastroenterology in 1991 at the Assistance Publique Hopitaux de Paris, and her Ph.D. in immunology at the University Paris, VII in 1996. From 1999 to 2002, Dr. Jabri worked in research at Princeton University, after which she joined the University of Chicago. During this period, she was member of the Gastroenterology Mucosal Pathobiology National Institute of Health and Crohn’s and Colitis Foundation study sections.

She has co-authored numerous high impact articles in peer-reviewed publications on celiac disease, mucosal immunology and IL-15. She has also been awarded the coveted Warren Prize for Excellence in Celiac Disease Research—a first for anyone in the United States, was elected to the Kunkel Society and the Association of American Physicians. One of Dr. Jabri’s most recent discoveries led to the initiation of Celimmune’s clinical trials aimed at targeting IL-15 in refractory celiac disease.

Joseph A. Murray, M.D.

Born in Ireland, Joseph A. Murray, M.D. attended medical school at the National University of Ireland in Galway, followed by internal medicine training at Trinity College in Dublin and internal medicine and gastroenterology training at Beaumont Hospital in Dublin. He further trained at the University of Iowa as a Fellow in Gastroenterology and Hepatology, and earned his Doctorate of Medicine by thesis from the National University of Ireland in Galway in 1992. Dr. Murray leads a large celiac disease program in the upper Midwest. He has a strong background and experience in basic and clinical gastroenterology, focusing primarily on celiac disease and immune-related disorders of the small intestine. He is a member of many national/international professional scientific committees and review boards, including membership in the Gastrointestinal Mucosal Pathobiology Study Section of the National Institutes of Health. He has served on editorial boards of several journals and is a senior associate editor for the American Journal of Gastroenterology.

He is the author/co-author of more than 220 scientific publications and 30 chapters. His work is funded by the NIH, private foundations and commercial entities. He is a past president and founding member of the North American Society for the Study of Celiac Disease, a fellow of the American Gastroenterologic Association and American College of Gastroenterology and a member of American Association of Immunology, American Motility Society, and serves on advisory boards for lay support groups and consults with several companies on the topic of celiac disease. His current work spans basic and translational research in the realm of celiac disease focusing on immunology, genetics of the disease and immune responses to food proteins.